LUMA Vision, a maker of 4D cardiac imaging and navigation platform, has secured $22 million in Series A3 financing led by existing and new investors. The company, which developed VERAFEYE, a cardiac-focused 4D imaging and navigation platform, aims to use the funds for FDA clearance in the U.S., commercialization, and further platform development. The CEO stated that the goal is to provide accurate, real-time data at the point of care for physicians to successfully treat a variety of conditions. Other companies offering 4D technology include GE Healthcare and Canon Medical Systems. LUMA Vision plans to be a bedrock of medical imaging for many years to come.
Source link
4D cardiac imaging company LUMA Vision secures $22M
